Home/Filings/4/0001628280-25-050825
4//SEC Filing

Merrell Brendan W. 4

Accession 0001628280-25-050825

CIK 0001448431other

Filed

Nov 9, 7:00 PM ET

Accepted

Nov 10, 9:55 AM ET

Size

9.0 KB

Accession

0001628280-25-050825

Insider Transaction Report

Form 4
Period: 2025-08-21
Merrell Brendan W.
CHIEF OPERATING OFFICER
Transactions
  • Tax Payment

    Common Stock

    2025-10-03$18.75/sh483$9,05627,208 total
  • Award

    Stock Option

    2025-08-21+23,43746,874 total
    Exercise: $16.14Exp: 2030-08-21Common Stock (23,437 underlying)
  • Award

    Common Stock

    2025-08-21+10,41727,691 total
Footnotes (3)
  • [F1]Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 21, 2026, which is the first anniversary of the grant date.
  • [F2]These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.
  • [F3]The stock option vests in three equal annual installments beginning August 21, 2026, the first anniversary of the grant date.

Issuer

OptimizeRx Corp

CIK 0001448431

Entity typeother

Related Parties

1
  • filerCIK 0002090383

Filing Metadata

Form type
4
Filed
Nov 9, 7:00 PM ET
Accepted
Nov 10, 9:55 AM ET
Size
9.0 KB